| |
 |
|
|
|
AngioGenetics is focusing on novel therapeutics affecting blood vessel
formation for use in e.g. cancer and cardiovascular disease.
AngioGenetics identifies and validates drug targets and aims to
identify, optimize, and commercialize lead compounds. The scientific
platform is based on research at Gothenburg University and the
Karolinska Institute.
www.angiogenetics.se
|
|
| |
|
|
|
